ID   TAOK1_HUMAN             Reviewed;        1001 AA.
AC   Q7L7X3; A2RUT8; B7ZLV6; Q96L75; Q9H2K7; Q9H7S5; Q9P2I6;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   15-FEB-2017, entry version 132.
DE   RecName: Full=Serine/threonine-protein kinase TAO1;
DE            EC=2.7.11.1;
DE   AltName: Full=Kinase from chicken homolog B;
DE            Short=hKFC-B;
DE   AltName: Full=MARK Kinase;
DE            Short=MARKK;
DE   AltName: Full=Prostate-derived sterile 20-like kinase 2;
DE            Short=PSK-2;
DE            Short=PSK2;
DE            Short=Prostate-derived STE20-like kinase 2;
DE   AltName: Full=Thousand and one amino acid protein kinase 1;
DE            Short=TAOK1;
DE            Short=hTAOK1;
GN   Name=TAOK1; Synonyms=KIAA1361, MAP3K16, MARKK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=13679851; DOI=10.1038/sj.onc.1206605;
RA   Yustein J.T., Xia L., Kahlenburg J.M., Robinson D., Templeton D.,
RA   Kung H.-J.;
RT   "Comparative studies of a new subfamily of human Ste20-like kinases:
RT   homodimerization, subcellular localization, and selective activation
RT   of MKK3 and p38.";
RL   Oncogene 22:6129-6141(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jenkins S.G., D'Andrea R.J., Gamble J.R., Vadas M.A.;
RT   "Characterization of human TAO1.";
RL   Submitted (JUL-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Matsuda A., Yoneta S.;
RT   "T cell activating gene.";
RL   Patent number WO2004058805, 15-JUL-2004.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=9786855; DOI=10.1074/jbc.273.44.28625;
RA   Hutchison M., Berman K.S., Cobb M.H.;
RT   "Isolation of TAO1, a protein kinase that activates MEKs in stress-
RT   activated protein kinase cascades.";
RL   J. Biol. Chem. 273:28625-28632(1998).
RN   [10]
RP   FUNCTION.
RX   PubMed=12665513; DOI=10.1074/jbc.M301173200;
RA   Chen Z., Raman M., Chen L., Lee S.F., Gilman A.G., Cobb M.H.;
RT   "TAO (thousand-and-one amino acid) protein kinases mediate signaling
RT   from carbachol to p38 mitogen-activated protein kinase and ternary
RT   complex factors.";
RL   J. Biol. Chem. 278:22278-22283(2003).
RN   [11]
RP   FUNCTION, PROTEOLYTIC PROCESSING, AND MUTAGENESIS OF LYS-57 AND
RP   ASP-376.
RX   PubMed=16407310; DOI=10.1074/jbc.M513769200;
RA   Zihni C., Mitsopoulos C., Tavares I.A., Ridley A.J., Morris J.D.;
RT   "Prostate-derived sterile 20-like kinase 2 (PSK2) regulates apoptotic
RT   morphology via C-Jun N-terminal kinase and Rho kinase-1.";
RL   J. Biol. Chem. 281:7317-7323(2006).
RN   [12]
RP   INTERACTION WITH MAP3K7.
RX   PubMed=16893890; DOI=10.1074/jbc.M603627200;
RA   Huangfu W.C., Omori E., Akira S., Matsumoto K., Ninomiya-Tsuji J.;
RT   "Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-
RT   mediated NF-kappaB activation: TAO2 regulates TAK1 pathways.";
RL   J. Biol. Chem. 281:28802-28810(2006).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [14]
RP   FUNCTION, PHOSPHORYLATION BY ATM, INDUCTION, AND MUTAGENESIS OF
RP   ASP-169; THR-643; THR-785 AND SER-990.
RX   PubMed=17396146; DOI=10.1038/sj.emboj.7601668;
RA   Raman M., Earnest S., Zhang K., Zhao Y., Cobb M.H.;
RT   "TAO kinases mediate activation of p38 in response to DNA damage.";
RL   EMBO J. 26:2005-2014(2007).
RN   [15]
RP   POSSIBLE ROLE IN SPINDLE CHECKPOINT.
RX   PubMed=17417629; DOI=10.1038/ncb1569;
RA   Draviam V.M., Stegmeier F., Nalepa G., Sowa M.E., Chen J., Liang A.,
RA   Hannon G.J., Sorger P.K., Harper J.W., Elledge S.J.;
RT   "A functional genomic screen identifies a role for TAO1 kinase in
RT   spindle-checkpoint signalling.";
RL   Nat. Cell Biol. 9:556-564(2007).
RN   [16]
RP   FUNCTION.
RX   PubMed=17900936; DOI=10.1016/j.cellbi.2007.08.006;
RA   Wu M.F., Wang S.G.;
RT   "Human TAO kinase 1 induces apoptosis in SH-SY5Y cells.";
RL   Cell Biol. Int. 32:151-156(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421 AND SER-965, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421 AND SER-445, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-421 AND THR-669,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-421, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   LACK OF ROLE IN SPINDLE CHECKPOINT.
RX   PubMed=19904549; DOI=10.1007/s00412-009-0244-2;
RA   Hubner N.C., Wang L.H., Kaulich M., Descombes P., Poser I., Nigg E.A.;
RT   "Re-examination of siRNA specificity questions role of PICH and Tao1
RT   in the spindle checkpoint and identifies Mad2 as a sensitive target
RT   for small RNAs.";
RL   Chromosoma 119:149-165(2010).
RN   [24]
RP   LACK OF ROLE IN SPINDLE CHECKPOINT.
RX   PubMed=20162290; DOI=10.1007/s00412-010-0261-1;
RA   Westhorpe F.G., Diez M.A., Gurden M.D., Tighe A., Taylor S.S.;
RT   "Re-evaluating the role of Tao1 in the spindle checkpoint.";
RL   Chromosoma 119:371-379(2010).
RN   [25]
RP   PHOSPHORYLATION BY LRRK2.
RX   PubMed=20949042; DOI=10.1371/journal.pone.0013191;
RA   Zach S., Felk S., Gillardon F.;
RT   "Signal transduction protein array analysis links LRRK2 to Ste20
RT   kinases and PKC zeta that modulate neuronal plasticity.";
RL   PLoS ONE 5:E13191-E13191(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-421, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9; SER-421; SER-445 AND
RP   SER-965, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [30]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-855.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various
CC       processes such as p38/MAPK14 stress-activated MAPK cascade, DNA
CC       damage response and regulation of cytoskeleton stability.
CC       Phosphorylates MAP2K3, MAP2K6 and MARK2. Acts as an activator of
CC       the p38/MAPK14 stress-activated MAPK cascade by mediating
CC       phosphorylation and subsequent activation of the upstream MAP2K3
CC       and MAP2K6 kinases. Involved in G-protein coupled receptor
CC       signaling to p38/MAPK14. In response to DNA damage, involved in
CC       the G2/M transition DNA damage checkpoint by activating the
CC       p38/MAPK14 stress-activated MAPK cascade, probably by mediating
CC       phosphorylation of MAP2K3 and MAP2K6. Acts as a regulator of
CC       cytoskeleton stability by phosphorylating 'Thr-208' of MARK2,
CC       leading to activate MARK2 kinase activity and subsequent
CC       phosphorylation and detachment of MAPT/TAU from microtubules. Also
CC       acts as a regulator of apoptosis: regulates apoptotic
CC       morphological changes, including cell contraction, membrane
CC       blebbing and apoptotic bodies formation via activation of the
CC       MAPK8/JNK cascade. {ECO:0000269|PubMed:12665513,
CC       ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:16407310,
CC       ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:17900936}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Serine/threonine-protein kinase activity is
CC       inhibited by SPRED1.
CC   -!- SUBUNIT: Self-associates. Interacts with MAP2K3 (By similarity).
CC       Interacts with SPRED1 and TESK1. Interacts with MAP3K7.
CC       {ECO:0000250, ECO:0000269|PubMed:16893890}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:13679851}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7L7X3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7L7X3-2; Sequence=VSP_015964, VSP_015965, VSP_015966;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q7L7X3-3; Sequence=VSP_043706;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the testis, and to a lower
CC       extent also expressed in brain, placenta, colon and skeletal
CC       muscle. {ECO:0000269|PubMed:13679851, ECO:0000269|PubMed:9786855}.
CC   -!- INDUCTION: In response to DNA damage.
CC       {ECO:0000269|PubMed:17396146}.
CC   -!- PTM: Proteolytically processed by caspase-3 (CASP3).
CC       {ECO:0000269|PubMed:16407310}.
CC   -!- PTM: Autophosphorylated (By similarity). Phosphorylated by ATM in
CC       response to DNA damage. Phosphorylated by LRRK2. {ECO:0000250,
CC       ECO:0000269|PubMed:17396146, ECO:0000269|PubMed:20949042}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Was initially thought to play a role in the spindle
CC       checkpoint (PubMed:17417629). However, it was later shown that it
CC       is not the case and that phenotypes initially observed are the
CC       cause of the siRNA used that has an off-target effect resulting in
CC       MAD2L1 inhibition (PubMed:19904549 and PubMed:20162290).
CC       {ECO:0000305|PubMed:17417629}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA92599.1; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF263312; AAG38502.1; -; mRNA.
DR   EMBL; AY049015; AAL12217.1; -; mRNA.
DR   EMBL; CQ834802; CAH05616.1; -; mRNA.
DR   EMBL; AB037782; BAA92599.1; ALT_INIT; mRNA.
DR   EMBL; AK024376; BAB14901.1; -; mRNA.
DR   EMBL; AC068025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068588; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090698; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471159; EAW51188.1; -; Genomic_DNA.
DR   EMBL; BC133039; AAI33040.1; -; mRNA.
DR   EMBL; BC144067; AAI44068.1; -; mRNA.
DR   CCDS; CCDS32601.1; -. [Q7L7X3-1]
DR   CCDS; CCDS56024.1; -. [Q7L7X3-3]
DR   RefSeq; NP_065842.1; NM_020791.2. [Q7L7X3-1]
DR   RefSeq; NP_079418.1; NM_025142.1. [Q7L7X3-3]
DR   RefSeq; XP_011523362.1; XM_011525060.2. [Q7L7X3-1]
DR   UniGene; Hs.597434; -.
DR   UniGene; Hs.735869; -.
DR   ProteinModelPortal; Q7L7X3; -.
DR   SMR; Q7L7X3; -.
DR   BioGrid; 121607; 13.
DR   DIP; DIP-39709N; -.
DR   IntAct; Q7L7X3; 9.
DR   MINT; MINT-5006389; -.
DR   STRING; 9606.ENSP00000261716; -.
DR   BindingDB; Q7L7X3; -.
DR   ChEMBL; CHEMBL5261; -.
DR   GuidetoPHARMACOLOGY; 2233; -.
DR   iPTMnet; Q7L7X3; -.
DR   PhosphoSitePlus; Q7L7X3; -.
DR   BioMuta; TAOK1; -.
DR   DMDM; 74759012; -.
DR   EPD; Q7L7X3; -.
DR   MaxQB; Q7L7X3; -.
DR   PaxDb; Q7L7X3; -.
DR   PeptideAtlas; Q7L7X3; -.
DR   PRIDE; Q7L7X3; -.
DR   Ensembl; ENST00000261716; ENSP00000261716; ENSG00000160551. [Q7L7X3-1]
DR   Ensembl; ENST00000536202; ENSP00000438819; ENSG00000160551. [Q7L7X3-3]
DR   GeneID; 57551; -.
DR   KEGG; hsa:57551; -.
DR   UCSC; uc002hdz.3; human. [Q7L7X3-1]
DR   CTD; 57551; -.
DR   DisGeNET; 57551; -.
DR   GeneCards; MIR4523; -.
DR   GeneCards; TAOK1; -.
DR   HGNC; HGNC:29259; TAOK1.
DR   HPA; HPA007669; -.
DR   MIM; 610266; gene.
DR   neXtProt; NX_Q7L7X3; -.
DR   OpenTargets; ENSG00000160551; -.
DR   PharmGKB; PA134872946; -.
DR   eggNOG; KOG0577; Eukaryota.
DR   eggNOG; ENOG410Y259; LUCA.
DR   GeneTree; ENSGT00810000125351; -.
DR   HOGENOM; HOG000236358; -.
DR   HOVERGEN; HBG088996; -.
DR   InParanoid; Q7L7X3; -.
DR   KO; K04429; -.
DR   OMA; AGPHWGH; -.
DR   OrthoDB; EOG091G01CN; -.
DR   PhylomeDB; Q7L7X3; -.
DR   TreeFam; TF351444; -.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   SignaLink; Q7L7X3; -.
DR   SIGNOR; Q7L7X3; -.
DR   ChiTaRS; TAOK1; human.
DR   GeneWiki; TAOK1; -.
DR   GenomeRNAi; 57551; -.
DR   PRO; PR:Q7L7X3; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000160551; -.
DR   CleanEx; HS_TAOK1; -.
DR   ExpressionAtlas; Q7L7X3; baseline and differential.
DR   Genevisible; Q7L7X3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; NAS:HGNC.
DR   GO; GO:0016301; F:kinase activity; NAS:HGNC.
DR   GO; GO:0004672; F:protein kinase activity; NAS:HGNC.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0016740; F:transferase activity; NAS:HGNC.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0097194; P:execution phase of apoptosis; IDA:UniProtKB.
DR   GO; GO:0031572; P:G2 DNA damage checkpoint; IMP:UniProtKB.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IDA:UniProtKB.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; NAS:HGNC.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; ISS:UniProtKB.
DR   GO; GO:0007062; P:sister chromatid cohesion; TAS:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Coiled coil;
KW   Complete proteome; Cytoplasm; DNA damage; DNA repair; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1   1001       Serine/threonine-protein kinase TAO1.
FT                                /FTId=PRO_0000086728.
FT   DOMAIN       28    281       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      34     42       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   COILED      458    651       {ECO:0000255}.
FT   COILED      754    877       {ECO:0000255}.
FT   COMPBIAS    330    334       Poly-Glu.
FT   COMPBIAS    347    379       Ser-rich.
FT   ACT_SITE    151    151       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      57     57       ATP. {ECO:0000305}.
FT   MOD_RES       9      9       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     421    421       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     445    445       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     669    669       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     965    965       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    174       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015964.
FT   VAR_SEQ     569    716       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_043706.
FT   VAR_SEQ     569    572       ELNE -> VLMS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015965.
FT   VAR_SEQ     573   1001       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_015966.
FT   VARIANT     855    855       A -> T (in dbSNP:rs34151057).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041204.
FT   MUTAGEN      57     57       K->A: Abolishes kinase activity, ability
FT                                to activate the MAPK8/JNK cascade and
FT                                cleavage by caspase-3 (CASP3).
FT                                {ECO:0000269|PubMed:16407310}.
FT   MUTAGEN     169    169       D->A: Loss of serine/threonine-protein
FT                                kinase activity.
FT                                {ECO:0000269|PubMed:17396146}.
FT   MUTAGEN     376    376       D->N: Does not abolish cleavage by
FT                                caspase-3 (CASP3).
FT                                {ECO:0000269|PubMed:16407310}.
FT   MUTAGEN     643    643       T->A: Abolishes phosphorylation by ATM;
FT                                when associated with A-785 and A-990.
FT                                {ECO:0000269|PubMed:17396146}.
FT   MUTAGEN     785    785       T->A: Abolishes phosphorylation by ATM;
FT                                when associated with A-643 and A-990.
FT                                {ECO:0000269|PubMed:17396146}.
FT   MUTAGEN     990    990       S->A: Abolishes phosphorylation by ATM;
FT                                when associated with A-643 and A-785.
FT                                {ECO:0000269|PubMed:17396146}.
FT   CONFLICT    251    251       S -> T (in Ref. 5; BAB14901).
FT                                {ECO:0000305}.
FT   CONFLICT    257    257       F -> S (in Ref. 1; AAG38502).
FT                                {ECO:0000305}.
FT   CONFLICT    860    860       R -> C (in Ref. 1; AAG38502).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1001 AA;  116070 MW;  82941DEAEADC7651 CRC64;
     MPSTNRAGSL KDPEIAELFF KEDPEKLFTD LREIGHGSFG AVYFARDVRT NEVVAIKKMS
     YSGKQSTEKW QDIIKEVKFL QRIKHPNSIE YKGCYLREHT AWLVMEYCLG SASDLLEVHK
     KPLQEVEIAA ITHGALQGLA YLHSHTMIHR DIKAGNILLT EPGQVKLADF GSASMASPAN
     SFVGTPYWMA PEVILAMDEG QYDGKVDVWS LGITCIELAE RKPPLFNMNA MSALYHIAQN
     ESPTLQSNEW SDYFRNFVDS CLQKIPQDRP TSEELLKHIF VLRERPETVL IDLIQRTKDA
     VRELDNLQYR KMKKLLFQEA HNGPAVEAQE EEEEQDHGVG RTGTVNSVGS NQSIPSMSIS
     ASSQSSSVNS LPDVSDDKSE LDMMEGDHTV MSNSSVIHLK PEEENYREEG DPRTRASDPQ
     SPPQVSRHKS HYRNREHFAT IRTASLVTRQ MQEHEQDSEL REQMSGYKRM RRQHQKQLMT
     LENKLKAEMD EHRLRLDKDL ETQRNNFAAE MEKLIKKHQA AMEKEAKVMS NEEKKFQQHI
     QAQQKKELNS FLESQKREYK LRKEQLKEEL NENQSTPKKE KQEWLSKQKE NIQHFQAEEE
     ANLLRRQRQY LELECRRFKR RMLLGRHNLE QDLVREELNK RQTQKDLEHA MLLRQHESMQ
     ELEFRHLNTI QKMRCELIRL QHQTELTNQL EYNKRREREL RRKHVMEVRQ QPKSLKSKEL
     QIKKQFQDTC KIQTRQYKAL RNHLLETTPK SEHKAVLKRL KEEQTRKLAI LAEQYDHSIN
     EMLSTQALRL DEAQEAECQV LKMQLQQELE LLNAYQSKIK MQAEAQHDRE LRELEQRVSL
     RRALLEQKIE EEMLALQNER TERIRSLLER QAREIEAFDS ESMRLGFSNM VLSNLSPEAF
     SHSYPGASGW SHNPTGGPGP HWGHPMGGPP QAWGHPMQGG PQPWGHPSGP MQGVPRGSSM
     GVRNSPQALR RTASGGRTEQ GMSRSTSVTS QISNGSHMSY T
//
